274 related articles for article (PubMed ID: 28297626)
21. Lymphoma classification update: T-cell lymphomas, Hodgkin lymphomas, and histiocytic/dendritic cell neoplasms.
Jiang M; Bennani NN; Feldman AL
Expert Rev Hematol; 2017 Mar; 10(3):239-249. PubMed ID: 28133975
[TBL] [Abstract][Full Text] [Related]
22. Peripheral T-cell lymphomas in children.
Agnarsson BA; Kadin ME
Semin Diagn Pathol; 1995 Nov; 12(4):314-24. PubMed ID: 8578026
[TBL] [Abstract][Full Text] [Related]
23. Non-Hodgkin's lymphomas of childhood and adolescence: results of a treatment stratified for biologic subtypes and stage--a report of the Berlin-Frankfurt-Münster Group.
Reiter A; Schrappe M; Parwaresch R; Henze G; Müller-Weihrich S; Sauter S; Sykora KW; Ludwig WD; Gadner H; Riehm H
J Clin Oncol; 1995 Feb; 13(2):359-72. PubMed ID: 7844597
[TBL] [Abstract][Full Text] [Related]
24. Expression of Grb2 distinguishes classical Hodgkin lymphomas from primary mediastinal B-cell lymphomas and other diffuse large B-cell lymphomas.
Miles RR; Mankey CC; Seiler CE; Smith LB; Teruya-Feldstein J; Hsi ED; Elenitoba-Johnson KS; Lim MS
Hum Pathol; 2009 Dec; 40(12):1731-7. PubMed ID: 19716163
[TBL] [Abstract][Full Text] [Related]
25. Childhood and adolescent non-Hodgkin lymphoma: new insights in biology and critical challenges for the future.
Cairo MS; Raetz E; Lim MS; Davenport V; Perkins SL
Pediatr Blood Cancer; 2005 Nov; 45(6):753-69. PubMed ID: 15929129
[TBL] [Abstract][Full Text] [Related]
26. Next Generation of Targeted Molecules for Non-Hodgkin Lymphomas: Small-Molecule Inhibitors of Intracellular Targets and Signaling Pathways.
Choe H; Ruan J
Oncology (Williston Park); 2016 Sep; 30(9):847-58. PubMed ID: 27633417
[TBL] [Abstract][Full Text] [Related]
27. Mutations of the 5' noncoding region of the BCL-6 gene in primary bone lymphomas.
Gianelli U; Ponzoni M; Moro A; Alfano RM; Pellegrini C; Giardini R; Patriarca C; Armiraglio E; Bosari S; Parafioriti A; Coggi G
Ann Hematol; 2003 Nov; 82(11):691-5. PubMed ID: 14513282
[TBL] [Abstract][Full Text] [Related]
28. Frequent expression of CD30 antigen in the primary gastric non-B, non-Hodgkin lymphomas.
Iwamizu-Watanabe S; Yamashita Y; Yatabe Y; Nakamura S; Mori N
Pathol Int; 2004 Jul; 54(7):503-9. PubMed ID: 15189504
[TBL] [Abstract][Full Text] [Related]
29. [Molecular abnormalities in lymphomas].
Delsol G
Bull Cancer; 2010 Nov; 97(11):1347-64. PubMed ID: 21084243
[TBL] [Abstract][Full Text] [Related]
30. Classification of non-Hodgkin's lymphomas in children.
Perkins SL; Segal GH; Kjeldsberg CR
Semin Diagn Pathol; 1995 Nov; 12(4):303-13. PubMed ID: 8578025
[TBL] [Abstract][Full Text] [Related]
31. [Molecular pathogenesis of peripheral T-cell lymphoma (1): angioimmunoblastic T-cell lymphoma, peripheral T-cell lymphoma, not otherwise specified and anaplastic large cell lymphoma].
Couronné L; Bastard C; Gaulard P; Hermine O; Bernard O
Med Sci (Paris); 2015 Oct; 31(10):841-52. PubMed ID: 26481023
[TBL] [Abstract][Full Text] [Related]
32. Report of an International Network of Cancer Treatment and Research workshop on non-Hodgkin's lymphoma in developing countries.
Naresh KN; Advani S; Adde M; Aziz Z; Banavali S; Bhatia K; Belgaumi A; Ezzat A; Khaled H; Mokhtar N; Norton A; Rohatiner A; Sagar TG; Taciyliz N; Temmim L; Venkatesh C; Yan Tang J; Magrath I
Blood Cells Mol Dis; 2004; 33(3):330-7. PubMed ID: 15528153
[TBL] [Abstract][Full Text] [Related]
33. Immunoreactivity of CD99 in non-Hodgkin's lymphoma: unexpected frequent expression in ALK-positive anaplastic large cell lymphoma.
Sung CO; Ko YH; Park S; Kim K; Kim W
J Korean Med Sci; 2005 Dec; 20(6):952-6. PubMed ID: 16361803
[TBL] [Abstract][Full Text] [Related]
34. Indications of next-generation sequencing in non-Hodgkin's lymphoma.
Heimann P; Dewispelaere L
Curr Opin Oncol; 2020 Sep; 32(5):391-397. PubMed ID: 32675596
[TBL] [Abstract][Full Text] [Related]
35. The aggressive peripheral T-cell lymphomas: 2015.
Armitage JO
Am J Hematol; 2015 Jul; 90(7):665-73. PubMed ID: 26031230
[TBL] [Abstract][Full Text] [Related]
36. Analysis of local control in patients with non-Hodgkin's lymphoma according to the WHO classification.
Sakata K; Satoh M; Someya M; Nagakura H; Oouchi A; Nakata K; Kogawa K; Koito K; Hareyama M; Himi T
Strahlenther Onkol; 2005 Jun; 181(6):385-91. PubMed ID: 15925981
[TBL] [Abstract][Full Text] [Related]
37. Integrin-specific hydrogels as adaptable tumor organoids for malignant B and T cells.
Tian YF; Ahn H; Schneider RS; Yang SN; Roman-Gonzalez L; Melnick AM; Cerchietti L; Singh A
Biomaterials; 2015 Dec; 73():110-9. PubMed ID: 26406451
[TBL] [Abstract][Full Text] [Related]
38. The helix-loop-helix protein Id2 is expressed differentially and induced by myc in T-cell lymphomas.
Cotta CV; Leventaki V; Atsaves V; Vidaki A; Schlette E; Jones D; Medeiros LJ; Rassidakis GZ
Cancer; 2008 Feb; 112(3):552-61. PubMed ID: 18085637
[TBL] [Abstract][Full Text] [Related]
39. Fas ligand expression in nodal non-Hodgkin's lymphoma.
Müllauer L; Mosberger I; Chott A
Mod Pathol; 1998 Apr; 11(4):369-75. PubMed ID: 9578088
[TBL] [Abstract][Full Text] [Related]
40. [Hodgkin and non-Hodgkin lymphoma of adolescents and young adults].
Garciaz S; Coso D; Brice P; Bouabdallah R
Bull Cancer; 2016 Dec; 103(12):1035-1049. PubMed ID: 27866679
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
